Evidence map›Paper›PMID 32216822›Full record

ArticleCritical care (London, England)2020

Factors associated with the development of septic shock in patients with candidemia: a post hoc analysis from two prospective cohorts.

Matteo Bassetti, Antonio Vena, Marco Meroi, Celia Cardozo, Guillermo Cuervo, Daniele Roberto Giacobbe, Miguel Salavert, Paloma Merino, Francesca Gioia, Mario Fernández-Ruiz and 21 more

Open access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Source Control inOpen forum infectious diseases · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Early-Onset Candidemia in Adult Intensive Care Units.Diagnostics (Basel, Switzerland) · 2025
    Review
  6. Article
  7. Emerging pathogens: the underestimated risk ofFrontiers in microbiology · 2025
    Article
  8. Article
  9. Article
  10. The FVirulence · 2023
    Article
  11. Article
  12. An Overview onJournal of fungi (Basel, Switzerland) · 2023
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Initial antimicrobial management of sepsis.Critical care (London, England) · 2021
    Review
  18. Article
  19. Article
  20. Rapid Detection Method for PathogenicInternational journal of nanomedicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 14 institutions in 2 countries.

Matteo BassettiInfectious Diseases Clinic, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Integrata, Piazzale Santa Maria della Misericordia 15, 33010, Udine, Italy. matteo.bassetti@unige.it.ORCID 0000-0002-2004-3724
Antonio VenaInfectious Diseases Clinic, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Integrata, Piazzale Santa Maria della Misericordia 15, 33010, Udine, Italy.
Marco MeroiInfectious Diseases Clinic, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Integrata, Piazzale Santa Maria della Misericordia 15, 33010, Udine, Italy.
Celia CardozoHospital Clínic, IDIBAPS (Institut d'Investigacions biomèdiques Agust Pi i Sunyer), Universitat de Barcelona, Barcelona, Spain.
Guillermo CuervoHospital Universitari de Bellvitge, IDIBELL (Institut D'Investigació Biomèdica de Bellvitge), Universitat de Barcelona, Barcelona, Spain.
Daniele Roberto GiacobbeDepartment of Health Sciences, University of Genoa, Genoa, Italy.
Miguel SalavertHospital Universitari I Politecnic "La Fe", Valencia, Spain.
Paloma MerinoHospital Universitario Clínico "San Carlos", Madrid, Spain.
Francesca GioiaHospital Universitario "Ramón y Cajal", Madrid, Spain.
Mario Fernández-RuizHospital Universitario "12 de Octubre", Instituto de Investigación Hospital "12 de Octubre" (i+12), Universidad Complutense de Madrid, Madrid, Spain.
Luis Eduardo López-CortésUnidad Clínica de Enfermedades Infecciosas y Microbiología Clínica, Hospital Universitario Virgen Macarena/Instituto de Biomedicina de Sevilla (IBiS)/Universidad de Sevilla/Centro Superior de Investigaciones Científicas, Seville, Spain.
Benito AlmiranteHospital Universitari Vall d'Hebron, VHIR (Vall d'Hebron Institut de Recerca), Universitat Autònoma de Barcelona, Barcelona, Spain.
Laura Escolà-VergéHospital Universitari Vall d'Hebron, VHIR (Vall d'Hebron Institut de Recerca), Universitat Autònoma de Barcelona, Barcelona, Spain.
Miguel MontejoHospital Universitario "Cruces", Bilbao, Spain.
Manuela Aguilar-GuisadoHospital Universitario "Virgen del Rocío", Sevilla, Spain.
Pedro Puerta-AlcaldeHospital Clínic, IDIBAPS (Institut d'Investigacions biomèdiques Agust Pi i Sunyer), Universitat de Barcelona, Barcelona, Spain.
Mariona TasiasHospital Universitari I Politecnic "La Fe", Valencia, Spain.
Alba Ruiz-GaitánHospital Universitari I Politecnic "La Fe", Valencia, Spain.
Fernando GonzálezHospital Universitario Clínico "San Carlos", Madrid, Spain.
Mireia Puig-AsensioHospital Universitari Vall d'Hebron, VHIR (Vall d'Hebron Institut de Recerca), Universitat Autònoma de Barcelona, Barcelona, Spain.
Francesc MarcoHospital Clínic, IDIBAPS (Institut d'Investigacions biomèdiques Agust Pi i Sunyer), Universitat de Barcelona, Barcelona, Spain.
Javier PemánHospital Universitari I Politecnic "La Fe", Valencia, Spain.
Jesus FortúnHospital Universitario "Ramón y Cajal", Madrid, Spain.
Jose Maria AguadoHospital Universitario "12 de Octubre", Instituto de Investigación Hospital "12 de Octubre" (i+12), Universidad Complutense de Madrid, Madrid, Spain.
Alejandro SorianoHospital Clínic, IDIBAPS (Institut d'Investigacions biomèdiques Agust Pi i Sunyer), Universitat de Barcelona, Barcelona, Spain.
Jordi CarrataláHospital Universitari de Bellvitge, IDIBELL (Institut D'Investigació Biomèdica de Bellvitge), Universitat de Barcelona, Barcelona, Spain.
Carolina Garcia-VidalHospital Clínic, IDIBAPS (Institut d'Investigacions biomèdiques Agust Pi i Sunyer), Universitat de Barcelona, Barcelona, Spain.
Maricela ValerioClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Assunta SartorMicrobiology Unit, Azienda Sanitaria Universitaria Integrata Santa Maria della Misericordia, Udine, Italy.
Emilio BouzaClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Patricia MuñozClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESHospital Universitari i Politècnic La Fe · ESUniversidad Complutense de Madrid · ESUniversitat Autònoma de Barcelona · ESUniversity of Udine · ITBellvitge University Hospital · ESHospital Clínico San Carlos · ESHospital Universitario Ramón y Cajal · ESHospital de Cruces · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario Virgen del Rocío · ESHospital Universitario Virgen Macarena · ESOspedale Policlinico San Martino · ITOspedale Santa Maria della Misericordia di Udine · IT

Funding

Instituto de Salud Carlos III PI15/00744
6 · The paper itself

Abstract

backgroundAlmost one third of the patients with candidemia develop septic shock. The understanding why some patients do and others do not develop septic shock is very limited. The objective of this study was to identify variables associated with septic shock development in a large population of patients with candidemia.

methodsA post hoc analysis was performed on two prospective, multicenter cohort of patients with candidemia from 12 hospitals in Spain and Italy. All episodes occurring from September 2016 to February 2018 were analyzed to assess variables associated with septic shock development defined according to The Third International Consensus Definition for Sepsis and Septic Shock (Sepsis-3).

resultsOf 317 candidemic patients, 99 (31.2%) presented septic shock attributable to candidemia. Multivariate logistic regression analysis identifies the following factors associated with septic shock development: age > 50 years (OR 2.57, 95% CI 1.03-6.41, p = 0.04), abdominal source of the infection (OR 2.18, 95% CI 1.04-4.55, p = 0.04), and admission to a general ward at the time of candidemia onset (OR 0.21, 95% CI, 0.12-0.44, p = 0.001). Septic shock development was independently associated with a greater risk of 30-day mortality (OR 2.14, 95% CI 1.08-4.24, p = 0.02).

conclusionsAge and abdominal source of the infection are the most important factors significantly associated with the development of septic shock in patients with candidemia. Our findings suggest that host factors and source of the infection may be more important for development of septic shock than intrinsic virulence factors of organisms.

Indexed as

AbdomenAgedAge FactorsCandidemiaFemaleHospitalizationHumansItalyMaleMiddle AgedProspective StudiesRisk FactorsShock, SepticSpainSurvival RateTreatment OutcomeCandidemiaIntra-abdominal candidiasisRisk factorsSeptic shock

Identifiers

PMID32216822
PMCPMC7099832
OpenAlexW3013345266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.